Originally published In Press as doi:10.1074/jbc.M201005200 on February 8, 2002
J. Biol. Chem., Vol. 277, Issue 17, 15013-15020, April 26, 2002
Passive Acquisition of Ligand by the MopII Molbindin from
Clostridium pasteurianum
STRUCTURES OF APO AND OXYANION-BOUND FORMS*
Alexander W.
Schüttelkopf
,
Jennifer A.
Harrison
,
David
H.
Boxer, and
William N.
Hunter§
From the The Wellcome Trust Biocentre, Division of Biological
Chemistry and Molecular Microbiology, School of Life Sciences,
University of Dundee, Dundee DD1 5EH, United Kingdom
Received for publication, January 30, 2002, and in revised form, February 6, 2002
 |
ABSTRACT |
MopII from Clostridium pasteurianum
is a molbindin family member. These proteins may serve as intracellular
storage facilities for molybdate, which they bind with high
specificity. High resolution structures of MopII in a number
of states, including the first structure of an apo-molbindin, together
with calorimetric data, allow us to describe ligand binding and provide
support for the proposed storage function of the protein. MopII
assembles as a trimer of dimers and binds eight oxyanions at two types
of binding sites located at intersubunit interfaces. Two type 1 sites
are on the molecular 3-fold axis and three pairs of type 2 sites occur on the molecular 2-fold axes. The hexamer is largely unaffected by the
binding of ligand. Molybdate is admitted to the otherwise inaccessible
type 2 binding sites by the movement of the N-terminal residues of each
protein chain. This contrasts with the structurally related
molybdate-dependent transcriptional regulator ModE, which undergoes extensive conformational rearrangements on ligand binding. Despite similarities between the binding sites of ModE and the type 2 sites of MopII the molbindin has a significantly reduced ligand
affinity, due, in part, to the high density of negative charges at the
center of the hexamer. In the absence of ligand this effects the
movement of an important lysine side chain, thereby partially
inactivating the binding sites. The differences are consistent with a
biological role in molybdate storage/buffering.
 |
INTRODUCTION |
Mop1
domains, which occur in a variety of bacterial and archeal proteins,
specifically bind molybdate. The simplest mop-containing proteins are
the so-called molbindins (1, 2), consisting entirely of either one or
two mop domains. The physiological role of these proteins is unclear,
although they have been implicated in molybdate storage and homeostasis
(3). Other mop-containing proteins are ModC, a component of the high
affinity ABC-type molybdate transporter (4) and ModE, the
molybdate-dependent transcriptional regulator (5, 6).
ModE-like proteins occur in a number of organisms such as
Escherichia coli, where this protein mediates both the
molybdate-dependent transcriptional repression of the
modABCD operon (MoO
transport (7-9)) and the molybdate-dependent activation of
the moaABCDE operon (molybdopterin biosynthesis (10)). ModE
also influences the expression of molybdoenzymes such as dimethyl
sulfoxide reductase (6) and nitrate reductase A (11). Functional ModE is a homodimeric protein, which folds into two distinct domains, an
N-terminal DNA-binding domain and a C-terminal molybdate-binding domain. The latter consists of four mop domains (two from each chain).
The structure of the mono-mop molbindin from Sporomusa ovata
in complex with tungstate (12) shows Mop subunits assembled into a
trimer of dimers forming eight oxyanion binding sites. A similar
arrangement was found for ModG from Azotobacter vinelandii, a di-mop molbindin. The crystal structure of this protein shows a
trimeric arrangement where one ModG molecule takes the place of each
Mop dimer (13). The structures of complete Escherichia coli
ModE in its apo form (14) as well as its ligand-bound C-terminal domain
(2) have been determined. The protein binds two molybdate anions per
dimer. The quaternary structure adopted by the four mop domains of the
dimer superimposes on two Mop dimers or two di-mops from the molbindins.
The nitrogen-fixing bacterium Clostridium pasteurianum
possesses three distinct genes encoding molbindins (15); the three proteins, Mop I through III, are
7 kDa in size and show a high degree of amino acid sequence conservation (>86% identity). They consist of a single mop domain and thus belong to the mono-mop molbindin family.
We report a number of high resolution crystal structures for C. pasteurianum MopII: two different structures of the apoprotein (Apo1 and Apo2), one structure of the tungstate complex, and two structures of Mop-molybdate complexes (Moo1 and Moo2, named after the
Protein Data Bank name for molybdate). The apoprotein and the
ligand-bound protein crystallized in different monoclinic crystal
forms, both with six Mop molecules per asymmetric unit. In the case of
the apoprotein they form a complete hexamer, whereas the ligand-bound
structures contain two separate Mop trimers, which are complemented to
hexamers by crystallographic symmetry. The structures provide the first
view of an apo-molbindin and allow us to characterize the mechanism by
which Mop acquires ligands and to compare this mechanism to that
described for ModE (2). Calorimetric studies complement the
crystallographic analysis, further characterizing molybdate binding to
Mop and enabling us to compare ligand affinities with those of ModE.
 |
EXPERIMENTAL PROCEDURES |
Crystallization, Data Collection, Structure Solution, and
Refinement--
The cloning, expression, and purification of MopII as
well as crystallization conditions and data collection procedures for the tungstate, Moo1, and Apo1 complexes are as previously described (16). After it was determined that the Moo1 structure contained only
partially loaded binding sites, more crystals were grown, but this time
with the addition of 1 µl of 8 mM
Na2MoO4 directly to the drop. Data from these
crystals were collected in-house using a Rigaku RU-200 rotating anode
x-ray source (Cu K
,
= 1.5418 Å) and an R-Axis
IV image plate detector. The resulting data set (Moo2) was processed
and scaled to 2.4 Å using DENZO/SCALEPACK (17).
In the hope of improving the resolution limit of the apo-structure
(Apo1: 1.8 Å) a second data set was collected in-house from a crystal
grown under the same conditions as described before (16). The
experimental setup, scaling, and processing were as for the Moo2 data;
the high resolution limit for the new data set (Apo2) is 1.5 Å.
Phases were obtained by single isomorphous replacement with anomalous
scattering (SIRAS) using the tungsten anomalous signal from the
tungstate data and the isomorphous differences between the tungstate
and the Moo1 data. We note that the partial occupancy of the
MoO
sites was fortuitous for the
phasing calculations. SOLVE (18) found and refined all eight oxyanion
sites, producing phases with a figure of merit
(FOM)2 of 0.47-2.0 Å.
Density modification using RESOLVE (19) improved the FOM to 0.72. The
resulting map was used with ARP/wARP in warpNtrace mode (20, 21) to
obtain an initial model containing 371 of the 408 expected amino acid
residues. Cycles of model building using O (22), water placement with
ARP/wARP, and refinement using CNS (23) and/or REFMAC (20, 24) led to
the final refined structure. The other data sets were solved by
molecular replacement with the refined tungstate structure using AMoRe
(25) and refined in a similar fashion. For a summary of data
collection, processing, and refinement statistics see Table
I.
Figs. 1A and 2 through 5 were generated with MOLSCRIPT (26)
and Raster3D (27). Fig. 1B was produced using ALSCRIPT (28). Cavity volumes were calculated with the program VOIDOO (29) using
default parameters.
MALDI-TOF Mass Spectrometry--
Experiments were carried out on
a Voyager MALDI-TOF (matrix-assisted laser desorption ionization
time-of-flight) mass spectrometer (Amersham Biosciences, Inc.) using a
sinapinic acid matrix. MopII was used as a 1 mg/ml solution in 50 mM Tris/HCl, pH 8.0, with and without addition of a 5-fold
molar excess of Na2MoO4.
Isothermal Titration Calorimetry (ITC)
Analysis--
Calorimetric measurements were performed using a VP-ITC
instrument (Microcal, Inc.). All experiments were carried out at
25 °C. The concentration of the MopII solutions was determined by the Bradford method (30), a necessity due to the absence of a (UV)
chromophore in the protein. A 100 µM solution of MopII in
50 mM Tris/HCl, pH 8.0, in the calorimetric cell was
titrated with sodium molybdate (concentrations between 0.5 and 1.5 mM in the injection syringe) dissolved in the same buffer.
The syringe was refilled with titrate during the measurements. As a
dilution correction a titration of buffer with sodium molybdate
solution in buffer was carried out. After integration, the determined
heat of dilution was subtracted from the heat of reaction. The data were integrated and analyzed using Origin 5 (Microcal, Inc.).
Coordinates--
The atomic coordinates and structure factors
have been deposited in the Protein Data Bank, Research Collaboratory
for Structural Bioinformatics, Rutgers University, New Brunswick, NJ
(www.rcsb.org). Accession codes are given in Table
I.
View this table:
[in this window]
[in a new window]
|
Table I
Data collection, processing, refinement, and model statistics
Numbers in parentheses refer to the highest resolution shell of about
0.1 Å width.
|
|
 |
RESULTS AND DISCUSSION |
Overall Structure--
The 68-amino acid Mop polypeptide consists
predominantly of
-strands (52% of the residues in six strands),
most of which (
2-
5) form a twisted antiparallel
-sheet. There
is also a short
-helix (10% of residues) between
4 and
5 and
two 310-helical segments (
1 and
2; 8% of residues)
between
3 and
4 and between
5 and
6, respectively (Fig.
1, A and B). In all
crystal structures six Mop subunits form a compact hexamer with
32-point group symmetry and a diameter of about 60 Å (Fig.
2, A and B). An
area of approximately 17,400 Å2 (
55% of the accessible
monomer surface) is buried upon oligomerization. The previous
structures of S. ovata Mop and ModG show a similar quaternary structure.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 1.
A, schematic representation of a
single C. pasteurianum MopII molecule. Secondary
structure elements are shown in blue ( -strands),
red ( -helix), or yellow
(310-helices) and labeled appropriately. All figures
represent the tungstate complex unless noted otherwise. The three
tungstate ions interacting with this subunit are shown as CPK models
and labeled T1 and T2 for type 1 and type 2 sites, respectively (see text). B, sequence alignment of
selected mop domains with the assigned secondary structure elements for
MopII. Residues shaded black, dark gray, and
light gray are identical in all sequences, in 80% and in
60% of sequences, respectively. Colored shading indicates
residues involved in type 1 site binding (blue), type 2 site
binding (yellow), and the central chamber (red).
For proteins with more than one mop per chain, mop domains are numbered
from the N terminus, and the numbers are given in square
brackets. H. influenzae = Hemophilus
influenzae, Rh. loti = Rhizobium
loti.
|
|

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 2.
A, stereo view of the complete hexameric
structure. Tungstate ions are shown as CPK models, and the dotted
gray line represents the molecular 3-fold symmetry axis.
B, the hexamer seen down the 3-fold axis. C,
subunit arrangement: The hexameric molecule can be abstracted as a
(distorted) trigonal antiprism with the six subunits (represented as
spheres and labeled by chain name) occupying its
corners. The edges of this antiprism represent the intersubunit
interfaces; they are colored by interface
type.
|
|
The Mop hexamer is observed by mass spectrometry and by native
polyacrylamide gel electrophoresis (data not shown). Moreover, considering that all ligand binding sites are formed through the interaction of two or more subunits, it is likely that the hexamer represents the functional unit. We are furthermore confident that the
reported hexameric apo-structures are physiologically meaningful, because the mass spectra show the hexamer peak even in the absence of ligand.
For the following discussion the six chains have been assigned chain
identifiers A through F as shown in Fig. 2C. We use these chain names to differentiate between the two trimers and more generally
the two poles of the molecule (ABC and DEF). In the case of the two
apo-structures, the chain names used are identical to those in the
deposited coordinate sets. The crystallographic symmetry in the
ligand-bound structures means that the chain identifiers A-F as used
here are actually chains A, B, C, A*, B*, C* or D*, E*, F*, D, E, F
(where X* is symmetry-related to X).
The hexamer possesses three unique intersubunit interfaces (Fig.
2C), one between subunits from the same trimer (yellow
edges in Fig. 2C) and two interfaces between subunits
from opposite trimers (both with internal 2-fold symmetry;
red and green edges). The most extensive
interaction occurs at the "red" interface, which
contributes ~3 × 2950 Å2 of the buried accessible
surface and involves 29 residues on each side. The main feature of this
interface is the interaction between
5 from either subunit and
6
from the other subunit. This results in the extension of the central
-sheets to two Greek-key
-barrels, which display
structural similarity to the oligonucleotide/oligosaccharide binding
fold (31). The interaction between
5 and
6' (primes are used to
denote a different chain) accounts for eight of the sixteen direct
hydrogen bonds formed across the red interface, the remaining hydrogen
bonds are formed between strand
4 and side chains from
2' as well
as backbone atoms from
2'. In addition to these direct interactions,
this interface also includes 16 water-bridged hydrogen-bonding contacts.
Contacts across the green interface (about 3 × 1180 Å2 of buried surface) are formed by 13 residues from helix
1, strands
1 and
4, and the 310-helix
2 on
either side; interactions include a salt bridge between
Arg6 and Glu46' and 10 direct hydrogen bonds.
Six of the eight oxyanion binding sites are formed at this interface
(see below).
The yellow interface buries 6 × 1040 Å2
of solvent-accessible surface area with about 70% of this surface
being hydrophobic in nature. Its principal feature is the antiparallel
alignment of
6 with
1', which is stabilized by three direct
hydrogen bonds and two bridging waters and further extends the central
-sheet. Strands
3 and
4 as well as
2 from both sides
participate in further contacts, providing three more direct hydrogen bonds.
With the exception of Apo2 (see below) the backbone conformations are
remarkably similar between subunits both within any structure (root
mean square deviation (r.m.s.d.) values for C
atoms
after pairwise alignment less than 0.4 Å) and between different structures (r.m.s.d. values for C
atoms less than 0.5 Å). In the case of the two apo-structures, an even higher degree of similarity is observed between subunits from the same trimer (r.m.s.d. less than 0.08 Å). The observed similarity is not an artifact of
refinement, because only weak restraints on non-crystallographic symmetry were applied or, in the case of Apo2, none at all.
The Ligand Binding Sites--
C. pasteurianum MopII
possesses eight oxyanion binding sites per hexamer, all of which make
use of the oligomeric assembly: two sites lie on the molecular 3-fold
axis at the centers of the two trimers, whereas the remaining six are
located at the green interfaces (Fig. 2, A and
B). In accordance with Wagner et al. (12) these
anion binding positions are referred to as type 1 and type 2 sites, respectively.
Type 1 sites are formed by the bend between
2 and
3 from three
Mop chains related by the molecular 3-fold axis (Figs. 1A, 2, and 3A). The symmetry of the binding site is mirrored by
the ligand binding mode: The central metal atom and one of the oxygen atoms lie on the 3-fold axis. This axial oxygen points into the hexamer, whereas the other three oxygens face outwards and each one
toward a different subunit (cf. Fig. 2B). The
bound oxyanion forms twelve hydrogen bonds with the protein, three of
them at the axial oxygen, which is contacted by the side-chain hydroxyl of Thr22 from all three Mop chains. The other oxygen atoms
each accept three hydrogen bonds from the backbone amides of
Val20, Val21, and Thr22 of one
protein molecule, although the latter is relatively weak at an average
distance of 3.3 Å. It is noteworthy that no positively charged groups
are involved in binding of the oxyanion at this site, in fact no such
groups exist within a radius of 9 Å from the oxyanion. With the
exception of a hydrogen bond from the Thr22 side chain,
interactions with the ligand are limited to the protein backbone.
The lack of sequence conservation for the residues involved (Fig.
1B) is consistent with this observation.
Type 2 sites occur in pairs at the three green interfaces and are
created by
1 as well as
2 from one subunit and the
1' helix
from the other subunit. The protein donates eight hydrogen bonds to the
ligand, five from
1/
2, and three from
1'. Two of the ligand
oxygens accept only one hydrogen bond (from the Ser4
hydroxyl and the Lys60 amine, respectively), the third
oxygen forms the remaining three hydrogen bonds with the same subunit
(with the Arg6 backbone amide and both the amide and the
side chain hydroxyl from Ser61). The fourth oxygen accepts
all three hydrogen bonds from the other subunit (amide and hydroxyl of
Ser40' and hydroxyl of Ser43' from consecutive
turns of the helix, Fig. 3B).
In this case partial compensation for the negative charge of the ligand
is afforded by the side chain of Lys60. Most of the
residues participating in the formation of type 2 sites are at least
functionally conserved, as should be expected given that most of them
contact the oxyanion with their side chains. Only Ser43 and
Ser61 are replaced by alanine or glycine in some molbindins
(Fig. 1B). Arg6 is conserved in almost all mop
proteins, despite the fact that its side chain does not contribute to
molybdate binding, instead forming an important salt bridge with
Glu46' as described above.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Representative binding sites
(tungstate-occupied). A, type 1 site; B,
type 2 site. Nitrogen and oxygen atoms are blue and
red, respectively. Protein residues are colored by
chain as in Fig. 2 and labeled by single-letter amino acid
code and residue number. Primes are used to differentiate between
polypeptide chains. Black dotted lines symbolize hydrogen
bonds. In B residue Ala5 is
semi-transparent, and the side chain of residue Arg6 has
been omitted for clarity.
|
|
Binding Sites in the Apo-structures--
Aside from a few
exceptions that will be described, the similarity in backbone
conformation between the various MopII structures can be extended to
the side-chain conformations, with subunit-subunit alignments typically
resulting in r.m.s.d. values below 0.7 Å for
480 atoms. Most of the
ligand binding sites in the apo-structures are also similar to the
corresponding ligand-filled sites. In the absence of ligand, the
positions of its oxygen atoms are populated by solvent atoms.
The best correspondence between apo- and ligand-bound structures is
observed for type 1 sites (Fig.
4A), alignment of Apo1 with
the tungstate complex puts solvent molecules within 0.7 Å of all
tungstate oxygens. However, a noticeable difference lies in the
position of Val20: Its side chains, which limit access to
the site from the bulk solvent, move slightly outwards in the apo forms
compared with ligand-bound structures, thereby widening the access bore
from an average diameter of 5.6 Å (ligand-bound) to ~7.5 Å (apo)
and thus facilitating ligand access. The slightly increased space requirements of the solvent structure compared with the oxyanion may
account for this.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 4.
Ligand binding sites in the apo-structures
and Moo1. Conventions as described for Fig. 3. Cyan and
yellow spheres represent water atoms and chloride ions,
respectively. The yellow tetrahedra denote the positions of
ligand oxygen atoms in the aligned tungstate structure. A,
representative type 1 site from Apo1. B, representative type
2 site from the DEF half of Apo1. C, representative type 2 site from the ABC half of Apo1. D, representative type 1 site from Moo1; the molybdate is shown as a ball-and-stick
model.
|
|
The three type 2 sites located closer toward the DEF pole of Apo1 are
also structurally similar to their liganded counterparts (Fig.
4B). One minor difference concerns the side chain of
Ser61, which appears in two alternate conformations in
Apo1. Again ligand oxygen equivalent positions are occupied by solvent
molecules. Only the solvent molecule hydrogen-bonding to the
Lys60 side chain is about 1.1 Å from the ideal position,
which allows it to form an additional hydrogen bond to the hydroxyl of
Ser61 in its alternate conformation (asterisk in
Fig. 4B). A more prominent difference is observed for the
type 2 sites closer to the ABC poles of both apo-structures (Fig.
4C): The side chain of Lys60 adopts a completely
different conformation pointing away from the binding site.
Subsequently, the solvent molecule that accepted a hydrogen bond from
Lys60 in the other sites has moved even further (up to 2.0 Å from the closest aligned oxyanion oxo position, not shown).
The largest difference from the ligand-bound structures can be observed
in the DEF half of Apo2 (Fig. 5): The
N-terminal six residues of chains A, B, and C (chain B in Fig. 5) move
up to 6 Å outwards, thereby partly exposing the type 2 site
underneath. Concomitantly minor movements of surrounding residues,
including the C terminus of a neighboring chain (chain A in Fig. 5) and residues 46-48 from another chain (chain D in Fig. 5), can be observed. This more open conformation demonstrates how the otherwise solvent-inaccessible type 2 sites may acquire ligand molecules.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 5.
Comparison of type 2 sites from the DEF half
of the tungstate complex (top) and Apo2
(bottom). The colors used are similar to those in
the previous figures. Protein residues are shown as CPK representations
and are labeled with the one-letter amino acid code, the
residue number, and the chain name. In the apo-structure the position
of the oxyanion from the superimposed tungstate structure is shown as
semi-transparent spheres.
|
|
Ligand Binding in Moo1--
Initial refinement of the Moo1 complex
resulted in the eight molybdenum atoms having unexpectedly high
temperature factors compared with their oxo ligands. Given the solvent
arrangement in the apo-structures, coupled with the absence of
lower-mass oxyanions from the crystallization conditions, we interpret
the observed electron density as resulting from partially
molybdate-occupied sites. The superposition of actual oxyanion oxygens
and solvent molecules (both with partial occupancy) mimics fully
occupied oxo ligands. The occupancies for the molybdenum atoms were
reduced to 0.5 and 0.25 for type 1 and type 2 sites, respectively,
which brought the temperature factors more in line with those of the surrounding protein atoms. A further indication of the partial ligand
occupancy in this structure is the observation that the side chain of
Lys60 exhibits a dual conformation in two of the protein
chains, pointing both toward the nearby type 2 site (as in the fully
loaded structures) and toward the center of the oligomer as in the
apo-subunits. The partially occupied binding sites in Moo1 also
underline the lack of structural differences between apo- and
ligand-bound Mop.
In addition, the oxyanions in the two type 1 sites of Moo1 adopt a
different orientation from the one seen in the other loaded structures:
The ligand is again oriented along the 3-fold axis, only now the axial
oxygen points outwards. The three equatorial oxygens are in
approximately the same position as in the other structures (Fig.
4D). The hydrogen bond donors and the number of hydrogen
bonds are the same for both orientations, differing only in relative
strength. While in the tungstate and Moo2 structures the interaction
with the backbone amide of Thr22 is weakest, in Moo1 the
most distant interaction is with the Val20 amide (distances
about 3.5 Å). It is noteworthy that, similar to the other ligand
oxygens, the new axial oxygen position is occupied by a water molecule
in some of the apo-trimers, suggesting that this binding mode is not
fundamentally disadvantaged, even though the temperature factors for
this water is about double that of its neighbors.
Thermodynamics of Ligand Binding--
To better establish the
properties of the different binding sites and to gain insight into the
possible function of molbindins, we characterized molybdate binding by
isothermal titration calorimetry (ITC (32, 33)) (Fig.
6). Although we cannot exclude the
possibility of cooperativity between some anion binding sites, we find
a reasonable fit for our data using a model with two types of
independent sites, which is in accordance with the structural evidence.
The results are summarized in Table
II.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
ITC titration data describing the binding of
molybdate to C. pasteurianum MopII. Differential
power signal recorded in a representative experiment (top)
and integrated data (dots) and fitted curve (solid
line) from the same experiment (bottom).
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Thermodynamic data for molybdate binding to C. pasteurianum MopII
Ka, association constant; n, number of
sites per Mop molecule; H, heat of binding;
G, free energy of binding; S, entropy of
binding. Errors on Ka, H, and
n are standard deviations from triplicate experiments; those
on G and S are propagated errors.
|
|
The two sets of site parameters were assigned to type 1 and type 2 sites based on the refined values for n (number of sites per
molecule); even though at 0.61 and 1.58 both experimental values are
larger than expected, their ratio
(n1/n2 = 0.39) correlates well with the expected value of 0.33 (for one-third type 1 site and
one-type 2 site per Mop molecule). The single largest error influencing
the absolute values for n is likely to stem from the estimate of protein concentration. Because this error is compensated for by n it should not affect the quality of the remaining results.
The association constants Ka show that type 1 sites have a more than one order of magnitude higher affinity for
molybdate than type 2 sites. This corresponds to the relative binding
affinities established independently by the different site occupancies
in the Moo1 structure.
The small changes between unbound and bound state, in terms of van der
Waals and hydrogen bonding interactions, and the lack of strong
electrostatic interactions in type 1 sites, suggest that binding
enthalpy should be small (
H
0). Thus the main driving force for binding is the entropic gain (
S > 0) from the displacement of four ordered waters by one ligand molecule;
this is corroborated by the experimental data. For type 2 sites the situation is similar, but as ligand binding localizes both the side
chains of Lys60 and Ser61 and the N-terminal
flap,
S is reduced. At the same time
H
becomes more negative due to the electrostatic interaction between the ligand and the side chain of Lys60, resulting in a slightly
larger enthalpic contribution to ligand binding.
The only other mop protein for which binding constants are published is
ModE from E. coli (5), which binds molybdate with a
Ka of ~1.3 × 106
M
1 in its two type 2 sites. The lower
affinity determined for the type 2 sites of MopII
(Ka
2.1 × 105
M
1) is compatible with a proposed
intracellular role as a passive molybdate storage facility. In the
absence of a specific energy-driven ligand extraction mechanism, a
storage protein must bind less strongly than the proteins that utilize
the stored ligand.
The Central Chamber--
At the center of the Mop hexamer there is
an extensive solvent-filled chamber with a volume of 472 Å2 (measured for the tungstate structure). The wall of the
cavity is lined with (partially) negatively charged entities, in
particular the side chains of Asp63 and the backbone
carbonyls of Lys60 and Thr62 from all six
chains. Based on their coordination, some of the solvent molecules in
the chamber were assigned to be Mg2+, Ca2+, or
Na+ ions.
The high local concentration of negative charges is especially
remarkable in the context of the conformational change of the Lys60 side chain in the apo-structures. The side chain,
which otherwise forms part of a type 2 binding site, positions its
amino group in the central plane between the two trimers and within 3.5 Å of two Asp63 carboxylates. This conformation is adopted
by half of the apo-Mop subunits in the Apo1 and Apo2 structures, the
maximum number possible without clashes between lysines from opposite
trimers. Given that this is the preferred conformation in
apo-structures and that the absence of Lys60 is likely
detrimental to type 2 site binding, this observation may in part
explain the reduced ligand affinity of the MopII type 2 sites compared
with ModE, which, as explained above, is essential for the storage
function of Mop. Additionally, the central chamber may furnish a place
for storing counterions and thus provide protection from unrestricted
charge separation; the presence of cations in the chamber would then
partly counteract the affinity-reducing effect. Asp63 is
functionally conserved (as aspartate or glutamate) in practically all
molbindins (Fig. 1B).
Comparison with Mop from S. ovata--
C. pasteurianum
MopII and S. ovata Mop are relatively similar in amino
acid sequence (37% sequence identity, see Fig. 1B). It
should be noted, however, that the sequence of the S. ovata Mop has been derived from the crystal structure (12) and may harbor
inaccuracies due to disordered or ambiguous electron density. The two
proteins exhibit identical subunit arrangement and similar backbone
conformations (r.m.s.d. about 0.7 Å for 396 superimposable C
atoms); the only difference of note is the deletion of Gly31 in the S. ovata structure.
The oxyanion binding sites are also similar; differences of note have
been listed in Table III. The ligands
bound to the type 1 sites of S. ovata Mop are in a
conformation comparable to that seen in the Moo1 structure (and were
also assigned a reduced occupancy). It is possible that for S. ovata Mop the Moo1-like binding mode is actually preferred,
because the replacement of Thr22 with a methionine may have
a greater deleterious effect on the normal binding mode than on the
Moo1-like mode. The central chamber is present in the S. ovata structure, but it is subdivided into several smaller
cavities due to the replacement of Asp63 with a
glutamate.
View this table:
[in this window]
[in a new window]
|
Table III
Comparison of ligand binding sites from different mop proteins
Amino acid changes (indicated by ) are only listed if they affect
the hydrogen bonding pattern. For ModG the sites located in the
N-terminal and C-terminal trimers are listed separately (labeled as
[N] and [C]).
|
|
Comparison with A. vinelandii ModG--
The di-mop molbindin ModG
from A. vinelandii is a 142-amino acid protein consisting of
a tandem repeat of mop domains. A crystal structure of molybdate-loaded
ModG (13) shows that ModG trimerizes to a hexa-mop arrangement similar
to that of the other molbindins: The 402 C
atoms of
ligand-bound C. pasteurianum Mop can be superimposed with an
r.m.s.d. of below 0.85 Å. Each ModG molecule corresponds to a pair of
Mop chains interacting across the red interface with the addition of a
five amino acid loop between the C terminus of one Mop and the N
terminus of the other. This connection introduces a polarity into the
hexa-mop arrangement, producing a C-terminal trimer and an N-terminal
trimer (the three ModG chains associate in a head-to-head fashion). All
ligands are still bound at intersubunit interfaces.
Again the ligand binding sites are similar to those found in Mop (see
Table III), and the ligand orientation is almost identical to that seen
in the fully oxyanion-loaded Mop structures for both types of sites.
Delarbre et al. (13) describe a hydrogen bonding network
between type 1 and type 2 sites in ModG and remark on the possible
implications for cooperative ligand binding. No such network is
observed in the MopII structures.
It is unlikely that the type 2 site loading mode proposed
for Mop is also applicable to ModG, because half of the Mop N termini are now in the middle of the polypeptide chain. Still the loop between
the two domains may be flexible enough to allow the required rearrangement. ModG is one of the few molbindins that lacks the conserved aspartate/glutamate of the central chamber. In its place there is an asparagine or a tryptophan.
Comparison with E. coli ModE--
ModE, like ModG, contains a
tandem repeat of mop domains, which in this case is attached to the C
terminus of a winged helix-turn-helix DNA-binding domain. The main
difference between ModE and the molbindins is that ModE is a dimer, not
a trimer. However, its four mop domains superimpose reasonably well
with appropriately chosen chains from the C. pasteurianum
Mop hexamer (r.m.s.d. 1.58 Å for 258 C
atoms using the
tungstate-bound ModE di-mop structure (2)). The ModE mop tetramer
cannot offer any type 1 ligand binding sites and can provide only two
type 2 sites between the N-terminal mop domains from both chains. The
ligand binding mode is similar to that of the other mop proteins (see
Table III for details).
As in the case of ModG the N termini of the individual mop domains of
ModE are unable to move freely, thus ligand acquisition cannot occur by
the passive mechanism proposed for Mop. Instead, the greater
flexibility of ModE allows the apoprotein to adopt a more open
structure with binding sites that are accessible from the bulk solvent.
Ligand binding results in an extensive conformational change involving
both inter- and intradomain movements, with the protein chomping on the
ligand (2). The more extensive rearrangements seen in ModE might be
beneficial for its functioning as a molybdate-dependent transcriptional regulator, possibly transmitting the signal of molybdate/tungstate binding to the DNA-binding domain. In light of the
sequence similarity among mop domains, it is remarkable how the basic
theme of molybdate binding is modulated to fit the requirements of
particular proteins. On the one hand there are signaling proteins like
ModE with high sensitivity and low binding capacity, and on the other
hand there is Mop as a storage protein with lower sensitivity but high
molybdate binding capacity.
 |
ACKNOWLEDGEMENTS |
We thank the Biological and
Biotechnology Sciences Research Council, UK and the Wellcome Trust for
funding and the staff at station PX9.6 of the SRS at Daresbury
Laboratory for their support. We also thank C. Bond, A. Cooper, D. Gourley, and D. Lamont for their help and useful discussions.
 |
FOOTNOTES |
*
This work was supported by the Biological and Biotechnology
Sciences Research Council, UK and the Wellcome Trust.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.
§
To whom correspondence should be addressed. Tel.: 44-1382-345-745;
Fax: 44-1382-345-764; E-mail: w.n.hunter@dundee.ac.uk.
Published, JBC Papers in Press, February 8, 2002, DOI 10.1074/jbc.M201005200
1
Mono-mop molbindins are generally known as Mop
proteins; we shall use "Mop" (uppercase) to refer to Mop proteins
and "mop" (lowercase) for mop domains.
 |
ABBREVIATIONS |
The abbreviations used are:
FOM, figure of
merit;
r.m.s.d., root-mean-square deviation;
ITC, isothermal titration
calorimetry;
MALDI-TOF, matrix-assisted laser desorption ionization
time-of-flight.
 |
REFERENCES |
| 1.
|
Lawson, D. M.,
Williams, C. E.,
White, D. J.,
Choay, A. P.,
Mitchenall, L. A.,
and Pau, R. N.
(1997)
J. Chem. Soc. Dalton Trans.
21,
3981-3984[CrossRef]
|
| 2.
|
Gourley, D. G.,
Schüttelkopf, A. W.,
Anderson, L. A.,
Price, N. C.,
Boxer, D. H.,
and Hunter, W. N.
(2001)
J. Biol. Chem.
276,
20641-20647[Abstract/Free Full Text]
|
| 3.
|
Grunden, A. M.,
and Shanmugam, K. T.
(1997)
Arch. Microbiol.
168,
345-354[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Pau, R. N.,
Klipp, W.,
and Leimkuhler, S.
(1997)
in
Iron and Related Transition Metals in Microbial Metabolism
(Winkelmann, G.
, and Carrano, C. J., eds)
, pp. 217-234, Harwood Academic Publishers, London, UK
|
| 5.
|
Anderson, L. A.,
Palmer, T.,
Price, N. C.,
Bornemann, S.,
Boxer, D. H.,
and Pau, R. N.
(1997)
Eur. J. Biochem.
246,
119-126[Medline]
[Order article via Infotrieve]
|
| 6.
|
McNicholas, P. M.,
Mazzotta, M. M.,
Rech, S. A.,
and Gunsalus, R. P.
(1998)
J. Bacteriol.
180,
4638-4643[Abstract/Free Full Text]
|
| 7.
|
Grunden, A. M.,
Self, W. T.,
Villain, M.,
Blalock, J. E.,
and Shanmugam, K. T.
(1999)
J. Biol. Chem.
274,
24308-24315[Abstract/Free Full Text]
|
| 8.
|
Rech, S.,
Deppenmeier, U.,
and Gunsalus, R. P.
(1995)
J. Bacteriol.
177,
1023-1029[Abstract/Free Full Text]
|
| 9.
|
Walkenhorst, H. M.,
Hemschemeier, S. K.,
and Eichenlaub, R.
(1995)
Microbiol. Res.
150,
347-361[Medline]
[Order article via Infotrieve]
|
| 10.
|
Anderson, L. A.,
McNairn, E.,
Leubke, T.,
Pau, R. N.,
and Boxer, D. H.
(2000)
J. Bacteriol.
182,
7035-7043[Abstract/Free Full Text]
|
| 11.
|
Self, W. T.,
Grunden, A. M.,
Hasona, A.,
and Shanmugam, K. T.
(1999)
Microbiology
145,
41-55[Abstract]
|
| 12.
|
Wagner, U. G.,
Stupperich, E.,
and Kratky, C.
(2000)
Structure
8,
1127-1136[Medline]
[Order article via Infotrieve]
|
| 13.
|
Delarbre, L.,
Stevenson, C. E. M.,
White, D. J.,
Mitchenall, L. A.,
Pau, R. N.,
and Lawson, D. M.
(2001)
J. Mol. Biol.
308,
1063-1079[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Hall, D. R.,
Gourley, D. G.,
Leonard, G. A.,
Duke, E. M. H.,
Anderson, L. A.,
Boxer, D. H.,
and Hunter, W. N.
(1999)
EMBO J.
18,
1435-1446[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Hinton, S. M.,
and Freyer, G.
(1986)
Nucleic Acids Res.
14,
9371-9380[Abstract/Free Full Text]
|
| 16.
|
Harrison, J. A.,
Schüttelkopf, A. W.,
Boxer, D. H.,
and Hunter, W. N.
(2001)
Acta Crystallogr. Sect. D Biol. Crystallogr.
57,
1715-1717[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Otwinowski, Z.,
and Minor, V.
(1997)
Methods Enzymol.
276,
307-326
|
| 18.
|
Terwilliger, T. C.,
and Berendzen, J.
(1999)
Acta Crystallogr. Sect. D Biol. Crystallogr.
55,
849-861[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Terwilliger, T. C.
(2000)
Acta Crystallogr. Sect. D Biol. Crystallogr.
56,
965-972[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Collaborative Computational Project Number 4.
(1994)
Acta Crystallogr. Sect. D Biol. Crystallogr.
50,
760-763[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Perrakis, A.,
Morris, R.,
and Lamzin, V. S.
(1999)
Nat. Struct. Biol.
6,
458-463[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Jones, T. A.,
Zou, J. Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. D Biol. Crystallogr.
47,
110-119
|
| 23.
|
Brünger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Murshudov, G. N.,
Vagin, A. A.,
and Dodson, E. J.
(1997)
Acta Crystallogr. Sect. D Biol. Crystallogr.
53,
240-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Navaza, J.
(1994)
Acta Crystallogr. Sect. A
50,
157-163[CrossRef]
|
| 26.
|
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
|
| 27.
|
Merrit, E. A.,
and Bacon, D. J.
(1997)
Methods Enzymol.
277,
505-524[Medline]
[Order article via Infotrieve]
|
| 28.
|
Barton, G. J.
(1993)
Protein Eng.
6,
37-40[Free Full Text]
|
| 29.
|
Kleywegt, G. J.,
and Jones, T. A.
(1994)
Acta Crystallogr. Sect. D Biol. Crystallogr.
50,
178-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Bradford, M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Murzin, A. G.
(1993)
EMBO J.
12,
861-867[Medline]
[Order article via Infotrieve]
|
| 32.
|
Wiseman, T.,
Williston, S.,
Brandts, J. F.,
and Lin, L. N.
(1989)
Anal. Biochem.
179,
131-137[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Cooper, A.,
and Johnston, C. M.
(1994)
Methods Mol. Biol.
22,
137-150[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.